Cynosure Lutronic reported that worldwide adoption of its XERF radiofrequency platform is accelerating, with the latest generation delivering 3x faster treatment cycles than prior versions. XERF is a fractional RF device positioned for skin tightening and collagen remodeling — a category that has seen renewed interest as practices seek non-invasive alternatives to surgical facelifts and compete on speed and comfort.
Devices & Tech
XERF Radiofrequency Adoption Accelerates — Cynosure Lutronic Reports 3x Speed Improvement
Cynosure Lutronic's XERF RF platform is gaining traction in practices; the latest iteration claims significantly faster treatment times.
XERF now delivers 3x faster treatment cycles, improving device throughput and ROI.
The speed improvement is clinically and economically significant. Faster RF treatments mean higher patient throughput per device per day, which directly improves device ROI and per-minute revenue. For practices evaluating RF platforms against competitors like InMode's Morpheus8 or Cutera's offerings, treatment time is now a material differentiator. The device is already in use at multiple U.S. practices, including Queen City Dermatology in Cincinnati, suggesting Cynosure is building momentum in the aesthetic dermatology channel. Practices considering RF investment should factor in the latest XERF specs when modeling break-even patient volume.
Source: original report ↗
Frequently asked questions
How much faster is the new XERF radiofrequency device compared to older models?
The latest XERF generation delivers 3x faster treatment cycles than prior versions. This speed improvement directly increases patient throughput per device per day, which improves ROI and per-minute revenue for practices.
What is XERF radiofrequency used for in medical aesthetics?
XERF is a fractional RF device positioned for skin tightening and collagen remodeling. It serves as a non-invasive alternative to surgical facelifts and appeals to practices competing on treatment speed and patient comfort.
How does XERF compare to Morpheus8 and other RF competitors?
Treatment time is now a material differentiator among RF platforms. For practices evaluating XERF against competitors like InMode's Morpheus8 or Cutera's offerings, the 3x speed improvement of the latest XERF generation is a significant advantage when modeling break-even patient volume and device ROI.
Is XERF radiofrequency already being used in U.S. practices?
Yes, XERF is already in use at multiple U.S. practices, including Queen City Dermatology in Cincinnati. This adoption suggests Cynosure is building momentum in the aesthetic dermatology channel.
What is the business impact of faster RF treatment times?
Faster treatment cycles mean higher patient throughput per device per day, which directly improves device ROI and per-minute revenue. This is clinically and economically significant for practices evaluating RF platform investments.
Free weekly brief
Get the free weekly brief.
The week's most important moves in medical aesthetics — distilled to a two-minute read, free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.